Omalizumab as Premedication for Hypersensitivity Reactions Refractory to Asparaginase Desensitization in Children With Acute Lymphoblastic Leukemia.

IF 6.6 3区医学 Q1 ALLERGY

Journal of Investigational Allergology and Clinical Immunology Pub Date : 2026-02-11 Epub Date: 2025-11-25 DOI:10.18176/jiaci.1118

Teodorikez-Wilfox Jimenez-Rodriguez, Angela Rico Rodes, Amparo Burgos San Jose, María Del Cañizo Moreira, Laura Ureña Horno, María E Valerio Alonso, Andrea Cano Rodriguez, Clara P Gallego Velez, María P González Delgado, María Tasso Cereceda

引用次数: 0

查看原文本刊更多论文

Omalizumab作为急性淋巴细胞白血病儿童天冬酰胺酶脱敏难治性超敏反应的预用药。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Investigational Allergology and Clinical Immunology 医学-过敏

CiteScore

7.10

自引率

9.70%

发文量

135

审稿时长

6-12 weeks

期刊介绍： The Journal of Investigational Allergology and Clinical Immunology (J Investig Allergol Clin Immunol) provides an attractive and very active forum for basic and clinical research in allergology and clinical immunology.Journal of Investigational Allergology and Clinical Immunology publishes original works, reviews, short communications and opinions.